Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144


Modulation of interferon expression by hepatitis C virus NS5A protein and human homeodomain protein PTX1.

Ghosh AK, Majumder M, Steele R, Ray R, Ray RB.

Virology. 2003 Feb 1;306(1):51-9.


Repression of virus-induced interferon A promoters by homeodomain transcription factor Ptx1.

Lopez S, Island ML, Drouin J, Bandu MT, Christeff N, Darracq N, Barbey R, Doly J, Thomas D, Navarro S.

Mol Cell Biol. 2000 Oct;20(20):7527-40.


Hepatitis C virus NS5A protein modulates transcription through a novel cellular transcription factor SRCAP.

Ghosh AK, Majumder M, Steele R, Yaciuk P, Chrivia J, Ray R, Ray RB.

J Biol Chem. 2000 Mar 10;275(10):7184-8.


Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication.

Polyak SJ, Paschal DM, McArdle S, Gale MJ Jr, Moradpour D, Gretch DR.

Hepatology. 1999 Apr;29(4):1262-71.


Reconstitution of virus-mediated expression of interferon alpha genes in human fibroblast cells by ectopic interferon regulatory factor-7.

Yeow WS, Au WC, Juang YT, Fields CD, Dent CL, Gewert DR, Pitha PM.

J Biol Chem. 2000 Mar 3;275(9):6313-20.


Promoter organization of the interferon-A genes differentially affects virus-induced expression and responsiveness to TBK1 and IKKepsilon.

Civas A, Génin P, Morin P, Lin R, Hiscott J.

J Biol Chem. 2006 Feb 24;281(8):4856-66. Epub 2005 Dec 27.


Repression by homeoprotein pitx1 of virus-induced interferon a promoters is mediated by physical interaction and trans repression of IRF3 and IRF7.

Island ML, Mesplede T, Darracq N, Bandu MT, Christeff N, Djian P, Drouin J, Navarro S.

Mol Cell Biol. 2002 Oct;22(20):7120-33.


Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with clinical response.

Paterson M, Laxton CD, Thomas HC, Ackrill AM, Foster GR.

Gastroenterology. 1999 Nov;117(5):1187-97.


Interferon-gamma regulation of the human mimecan promoter.

Tasheva ES, Conrad GW.

Mol Vis. 2003 Jun 30;9:277-87.


Preferential binding sites for interferon regulatory factors 3 and 7 involved in interferon-A gene transcription.

Morin P, Bragança J, Bandu MT, Lin R, Hiscott J, Doly J, Civas A.

J Mol Biol. 2002 Mar 8;316(5):1009-22.


Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines.

Zhang T, Lin RT, Li Y, Douglas SD, Maxcey C, Ho C, Lai JP, Wang YJ, Wan Q, Ho WZ.

Hepatology. 2005 Oct;42(4):819-27.


The hepatitis C virus non-structural NS5A protein inhibits activating protein-1 function by perturbing ras-ERK pathway signaling.

Macdonald A, Crowder K, Street A, McCormick C, Saksela K, Harris M.

J Biol Chem. 2003 May 16;278(20):17775-84. Epub 2003 Mar 5.


The non-structural 5A protein of hepatitis C virus exhibits genotypic differences in interferon antagonism.

Tsai YH, Kuang WF, Lu TY, Kao JH, Lai MY, Liu CJ, Chen PJ, Hwang LH.

J Hepatol. 2008 Dec;49(6):899-907. doi: 10.1016/j.jhep.2008.06.030. Epub 2008 Sep 16.


The N- and C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation.

Donelan NR, Dauber B, Wang X, Basler CF, Wolff T, García-Sastre A.

J Virol. 2004 Nov;78(21):11574-82.


Modulation of human luteinizing hormone beta gene transcription by MIP-2A.

Ghosh AK, Steele R, Ray RB.

J Biol Chem. 2003 Jun 27;278(26):24033-8. Epub 2003 Apr 16.


Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein.

Tu H, Gao L, Shi ST, Taylor DR, Yang T, Mircheff AK, Wen Y, Gorbalenya AE, Hwang SB, Lai MM.

Virology. 1999 Oct 10;263(1):30-41.

Supplemental Content

Support Center